Diabetes

The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

Liver disease | Image credit: Crystal light - stock.adobe.com
Fatty Liver Found in Half of Patients With Type 2 Diabetes, Study Finds

June 13th 2025

Nonalcoholic fatty liver disease (NAFLD) was linked to elevated liver enzymes in type 2 diabetes mellitus (T2DM) in a recent study, urging early detection and comprehensive care.

DASH diet | Image credit: Albi - stock.adobe.com
DASH-Style Diet Lowers Blood Pressure in Type 2 Diabetes

June 10th 2025

vials of insulin | Image credit: Sherry Young - stock.adobe.com
AI Matches Physician Accuracy in Insulin Dosing for T2D

May 30th 2025

Type 2 diabetes graphic | Image Credit: greenapple78 - stock.adobe.com
Concurrent Hypertension, Type 2 Diabetes Linked to Higher Mortality Risk

May 29th 2025

Insulin cost | Image credit: Pixel-Shot - stock.adobe.com
Diabetes Health Gains Outpace Economic Progress, Study Finds

May 16th 2025

Advancing Care in Type 2 Diabetes and Obesity: A Coordinated, Guideline-Driven Approach

Understand how recent advances in GLP-1 receptor agonists and other therapies are transforming the treatment of type 2 diabetes and obesity through a shift of reactive to proactive care that addresses root causes of cardiometabolic disease.

AJMC Peer Exchange geometric background

More News

Site Logo
January 3rd 2018

Medical World News: Business Updates

AJMC Staff
Site Logo
December 29th 2017

Cardiovascular Outcomes Are the Focus of Evidence-Based Diabetes ManagementTM, a Publication of The American Journal of Managed Care&reg

Cost considerations and potential for prevention covered in current issue of Evidence-Based Diabetes ManagementTM.
FDA Approves First Shock Wave Device to Treat Diabetic Foot Ulcers
December 29th 2017

FDA Approves First Shock Wave Device to Treat Diabetic Foot Ulcers

Allison Inserro
The FDA has approved the sale of the Dermapace System, the first shock wave device intended to treat diabetic foot ulcers.
Lifestyle Articles Top 2017 Favorites in Evidence-Based Diabetes ManagementTM
December 28th 2017

Lifestyle Articles Top 2017 Favorites in Evidence-Based Diabetes ManagementTM

Mary Caffrey
Adapting payment models to reward outcomes is key to making lifestyle change fit into a managed care framework, several articles find.
Site Logo
December 26th 2017

Perspectives of a Lipidologist: LDL Cholesterol Testing, PCSK9 Inhibitors

Mary Caffrey
Podcast: This Week in Managed Care—Individual Mandate Eliminated and Other Health News
December 23rd 2017

Podcast: This Week in Managed Care—Individual Mandate Eliminated and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This Week in Managed Care: December 22, 2017
December 22nd 2017

This Week in Managed Care: December 22, 2017

This week, the top managed care stories included the elimination of the Affordable Care Act's individual mandate; a new gene therapy for inherited vision loss that could cost $1 million; and a study found that social isolation can increase the risk of type 2 diabetes.
Site Logo
December 22nd 2017

Medical World News®, December 2017

AJMC Staff
Key drug approvals; alcohol cancer link.
Articles That Gained the Most Traction on Facebook, Twitter, and LinkedIn in 2017
December 22nd 2017

Articles That Gained the Most Traction on Facebook, Twitter, and LinkedIn in 2017

Jaime Rosenberg
Articles on type 2 diabetes management, colon cancer screenings, and anti-rheumatic drug approvals topped the list.
Dr Todd Hobbs Discusses Identifying and Removing Barriers to Care for Obesity
December 21st 2017

Dr Todd Hobbs Discusses Identifying and Removing Barriers to Care for Obesity

Although patients and physicians both recognize the need to discuss obesity, the lack of resources, time, and expertise often prevents physicians for offering care and patients from asking for it, explained Todd Hobbs, MD, Novo Nordisk’s vice president and chief medical officer.
New SGLT2 Competitor Steglatro Approved for Type 2 Diabetes
December 21st 2017

New SGLT2 Competitor Steglatro Approved for Type 2 Diabetes

Laura Joszt, MA
A new sodium-glucose co-transporter 2 medication to treat type 2 diabetes is joining the field: the FDA approved ertugliflozin (Steglatro) from Merck and Pfizer as a single therapy and in combination with Merck’s sitagliptin (Januvia), a DPP-4 inhibitor, or with metformin.
Conference Stories That Captivated AJMC® Readers in 2017
December 21st 2017

Conference Stories That Captivated AJMC® Readers in 2017

Samantha DiGrande
In 2017, The American Journal of Managed Care® (AJMC®) covered conferences on a range of topics: oncology, diabetes, managed care, and much more. however, the most-read coverage from conferences that AJMC® attended mostly focused on cardiology trial results, particularly the cardiovascular results of diabetes medications.
Dr Jay Edelberg Discusses Results of Alirocumab by Race and Ethnicity
December 21st 2017

Dr Jay Edelberg Discusses Results of Alirocumab by Race and Ethnicity

Trial results have shown that alirocumab (Praluent) is safe and effective across patient populations, said Jay Edelberg, MD, PhD, vice president and head of Cardiovascular Development and Cardiovascular Affairs at Sanofi.
Site Logo
December 19th 2017

The CVD-Real Trial: What Can Real-World Evidence Tell Us About Primary Prevention?

Mary Caffrey
An interview with one of the authors of a large observational study that has seen findings consistent with recent cardiovascular outcomes trials in SGLT2 inhibitors.
Links Between Social Isolation, Type 2 Diabetes Show Need for Friendships
December 19th 2017

Links Between Social Isolation, Type 2 Diabetes Show Need for Friendships

Mary Caffrey
A least one US payer, CareMore, has a program to combat loneliness in seniors to prevent chronic disease and other health problems.
Improved Recommendations of Deintensification in Clinical Guidelines Is Needed
December 19th 2017

Improved Recommendations of Deintensification in Clinical Guidelines Is Needed

Laura Joszt, MA
Currently, clinical guidelines offer little guidance on deintensifying care, which is critical for balancing overuse and underuse of services.
Site Logo
December 19th 2017

Amid Uproar Over CDC's 7 Words, a Question: Why Would "Evidence-Based" Cause a Stir?

Mary Caffrey
What the CEO of the American Association for the Advancement of Science thinks about the current controversy.
The Most-Read News Stories of 2017
December 18th 2017

The Most-Read News Stories of 2017

Laura Joszt, MA
The top 5 most-read news stories included clinical content, such as an FDA approval, and policy news, such as Medicare reimbursement coverage.
Site Logo
December 18th 2017

As Trials Report Cardiovascular Outcomes Data, What About Microvascular Results?

Andrew Smith
Evidence is more robust on kidney function but not sufficient to make drug decisions, one expert said. A whole separate trial, called CREDENCE, is examining renal function in patients taking canagliflozin.
Lack of Payer Support a Barrier to Diabetes Prevention, CDC Reports
December 17th 2017

Lack of Payer Support a Barrier to Diabetes Prevention, CDC Reports

Mary Caffrey
On the plus side, a partnership with the American Medical Association appears to have contributed to a rise in provider referrals to lifestyle modification programs.
Podcast: This Week in Managed Care—CAR T Treatments and Other Health News
December 16th 2017

Podcast: This Week in Managed Care—CAR T Treatments and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Site Logo
December 15th 2017

Evaluation of the Quality Blue Primary Care Program on Health Outcomes

Qian Shi, PhD, MPH Thomas J. Yan, MS Peter Lee, BS Paul Murphree, MD, MHA Xiaojing Yuan, MPH Hui Shao, PhD, MHA William H. Bestermann, MD Selina Loupe, BS Dawn Cantrell, BA David Carmouche, MD John Strapp, BA Lizheng Shi, PhD, MSPharm
Implementation of the Quality Blue Primary Care program in Louisiana was associated with a shift in primary care delivery and reductions in overall cost.
What We're Reading: Medicare Lab Testing; CHIP Deadline; AMA Expands Diabetes Efforts
December 15th 2017

What We're Reading: Medicare Lab Testing; CHIP Deadline; AMA Expands Diabetes Efforts

AJMC Staff
Medicare is alleging laboratories improperly billed the government for improper tests; time is running out for children receiving healthcare from CHIP; the AMA extends its diabetes prevention model to Maryland and other states.
This Week in Managed Care: December 15, 2017
December 15th 2017

This Week in Managed Care: December 15, 2017

This week, the top managed care news included coverage from the 59th American Society of Hematology Annual Meeting and Exposition; recommendations on the use of diabetes drugs with cardiovascular indications; and a new study found that despite changes in insurance plans to give consumers more clout, unnecessary medical spending remains a problem.
Site Logo
December 14th 2017

Moving Pharma Contracting Into the Era of Accountability

Thomas R. Graf, MD
A chief medical officer for a major payer outlines the challenges making sure that certain high-cost therapies are directed to the patients who need them.
Site Logo
December 14th 2017

Report Highlights Increase in Premature Deaths in the United States

Laura Joszt, MA
An analysis of behaviors, community environment, policy, clinical care, and outcomes data has found a disturbing trend in mortality in the United States, with premature deaths, drug deaths, and cardiovascular deaths all increasing.
Site Logo
December 14th 2017

For Those With Diabetes and CV Risk, Personalized Care Matters

Robert A. Gabbay, MD, PhD, FACP
From the Editor in Chief
Site Logo
December 13th 2017

MGH: Centralized population health coordinators help improve care for patients with chronic disease

Site Logo
December 13th 2017

Eldrin F. Lewis, MD, MPH, on Heart Failure's Place in Diabetes Drug Trials, and the Promise of SGLT2s in Prevention

Mary Caffrey
The payment reform movement has changed the thinking about what can be done for patients with diabetes and heart failure, for the good of patients.
Site Logo
December 12th 2017

“Sprint to Zero“: A Strategy to Address High Rates of Nontraumatic Amputations in Minority Communities

Jeffrey Carr, MD, FACC, FSCAI
CMS can take steps to raise awareness, including a specific quality measure, to ensure that testing occurs prior to nontraumatic amputation.
<1
...
293031323334353637
...
98>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo